Medical Cannabis Update 2021 Live Q&A : What Do We Tell Our Patients & Our Colleagues?-Session Presentation

Video Transcription

Video Summary

In this Q&A discussion on medical cannabis, Dr. Mitchell Pryor, the session director and moderator, introduces the panelists and discusses the challenges of advising patients about CBD products. Dr. Ethan Russo, a leading researcher on medical cannabis, explains that CBD is a safe compound but not very potent, so it may not have a strong therapeutic effect unless taken in large doses. He advises consumers to look for products that are backed by scientific research and have a Certificate of Analysis (COA) to ensure safety. The panel also discusses the medical, legal, and regulatory issues surrounding cannabis, including the need for better education for physicians and patients. They also touch on the potential use of cannabis for conditions such as traumatic brain injury, opiate use disorder, and cardiovascular disease. The panel emphasizes the importance of individualized treatment and caution against smoking cannabis, particularly for patients with cardiopulmonary issues. They also mention the lack of regulation and quality control for some cannabis products on the market. Overall, the panel highlights the need for more research, regulation, and education in the field of medical cannabis.

Keywords

medical cannabis

CBD products

advising patients

scientific research

Certificate of Analysis

individualized treatment

traumatic brain injury

opiate use disorder